Treatment of an Adolescent With Chronic Myeloid Leukemia and the T315I Mutation With Ponatinib

被引:21
|
作者
Nickel, Robert Sheppard [1 ]
Daves, Marla [1 ]
Keller, Frank [1 ]
机构
[1] Emory Univ, Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA
关键词
IMATINIB; GROWTH; CHILDREN;
D O I
10.1002/pbc.25551
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2050 / 2051
页数:2
相关论文
共 50 条
  • [41] Design, synthesis, and biological evaluation of Bcr-Abl PROTACs to overcome T315I mutation
    Jiang, Liang
    Wang, Yuting
    Li, Qian
    Tu, Zhengchao
    Zhu, Sihua
    Tu, Sanfang
    Zhang, Zhang
    Ding, Ke
    Lu, Xiaoyun
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (05) : 1315 - 1328
  • [42] Establishment of a new Philadelphia chromosome-positive acute lymphoblastic leukemia cell line (SK-9) with T315I mutation
    Okabe, Seiichi
    Tauchi, Tetsuzo
    Ohyashiki, Kazuma
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : 765 - 772
  • [43] T315I Mutation in Ph-positive Acute Lymphoblastic Leukemia is Associated with a Highly Aggressive Disease Phenotype: Three Case Reports
    Watanabe, Keisuke
    Minami, Yosuke
    Ozawa, Yukiyasu
    Miyamura, Koichi
    Naoe, Tomoki
    ANTICANCER RESEARCH, 2012, 32 (05) : 1779 - 1783
  • [44] A pyrosequencing-based test for detection and relative quantification of the BCR-ABL1 T315I point mutation
    Schumacher, Jonathan A.
    Szankasi, Philippe
    Bahler, David W.
    Ho, Albert K.
    Kelley, Todd W.
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (07) : 618 - 625
  • [45] Second cord blood transplantation and interferon- maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation
    Sumi, Masahiko
    Sato, Keijiro
    Kaiume, Hiroko
    Takeda, Wataru
    Kirihara, Takehiko
    Ueki, Toshimitsu
    Hiroshima, Yuki
    Kobayashi, Hikaru
    LEUKEMIA & LYMPHOMA, 2017, 58 (08) : 2005 - 2007
  • [46] Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase
    Haddad, Fadi G.
    Sasaki, Koji
    Nasr, Lewis
    Short, Nicholas J.
    Kadia, Tapan
    Dellasala, Sara
    Cortes, Jorge
    Nicolini, Franck E.
    Issa, Ghayas C.
    Jabbour, Elias
    Kantarjian, Hagop
    CANCER, 2024, 130 (19) : 3344 - 3352
  • [47] Bestinib, a novel Bcr-Abl inhibitor for Chronic Myeloid Leukemia, inhibits a wide array of Bcr-Abl mutants including imatinib resistant T315I mutant
    Gupta, Pranav
    Yang, Ke
    Wang, Fang
    Wang, Xiaokun
    Kathawala, Rishil J.
    Fu, Liwu
    Chen, Zhe Sheng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S100 - S100
  • [48] A nomogram for predicting T315I-free survival in chronic phase chronic myeloid leukemia patients: a multicenter retrospective study
    Hu, Shi-wei
    Yang, Xiu-di
    Wu, Di-jiong
    Wang, Yi
    Zhu, Xiao-qiong
    Feng, Wei-ying
    Qian, Hong-lan
    Lu, Ying
    Chen, Li-li
    Cao, Li-hong
    Le, Jing
    Zhang, Li
    Shao, Yan-ping
    Liu, Li-rong
    Tian, Guo-yan
    Zhou, Hui
    Chen, Yu
    Yin, Xiu-feng
    Feng, Xiao-ning
    Huang, Li
    Zhang, Kai-feng
    Xia, Yong-ming
    Xu, Lin-juan
    Zhang, Hui-qi
    Zhang, Gang
    Jia, Yong-qing
    Zhou, Xiu-jie
    Wu, Gong-qiang
    Tu, Jin-ming
    Zhu, Feng
    Zhang, Yue-feng
    Yao, Guo-li
    Zhu, Jing-jing
    Tong, Hong-yan
    Jin, Jie
    Huang, Jian
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [49] Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemia
    Chomel, Jean-Claude
    Sorel, Nathalie
    Bonnet, Marie-Laure
    Bertrand, Angelina
    Brizard, Francoise
    Roy, Lydia
    Guilhot, Francois
    Turhan, Ali G.
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2103 - 2111
  • [50] Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production
    Ko, Byung Woong
    Han, Jeongsu
    Heo, Jun Young
    Jang, Yunseon
    Kim, Soo Jeong
    Kim, Jungim
    Lee, Min Joung
    Ryu, Min Jeong
    Song, Ik Chan
    Jo, Young Suk
    Kweon, Gi Ryang
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2180 - 2188